Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Effects of reduced insulin-2 in beta cells of NOD mice

EF 2021-22

Résumé
Type 1 Diabetes (T1D) is a disease that affects ~1% of Canadians and is characterized by the death of insulin-producing beta cells within the pancreas. Insulin is an essential protein that triggers cells to absorb digested sugar (glucose) from the bloodstream for energy and storage. As the body’s only source of circulating insulin, beta cell death in T1D traps glucose in the blood and cells are starved of energy. Genetic predispositions are known to contribute to T1D by causing the body’s immune system to attack and destroy beta cells (autoimmunity). However, recent research has shown that beta cell stress and subsequent dysfunction may also have a role in beta cell death. Insulin production is a complex process which can stress beta cells. This stress increases the likelihood of faulty insulin production, which can cause the cell to activate suicide pathways, and possibly trigger an autoimmune reaction against these dysfunctional beta cells. We propose that decreasing insulin production will alleviate stress, thereby increasing beta cell survival and delaying diabetes onset. We plan to test this hypothesis by using mice predisposed to develop T1D and genetically reduce insulin production levels by injecting a beta cell-specific viral vector carrying an insulin-gene modifier. We will monitor diabetes incidence in the mice and measure biomarkers for beta cell stress and autoimmunity. While no cure currently exists for T1D, enhanced screening technology enables earlier detection of pre-diabetic patients. Understanding why beta cells die is essential to the development of future therapeutics. Preventative medicine could prolong beta cell survival and help maintain natural insulin production, changing the outcome of T1D predisposition.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
481149
Name
Nahirney Natalie
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of reduced insulin-2 in beta cells of NOD mice
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmunity; Beta Cell; Diabetes; Er Stress; Gene Reduction; Nod Mice; Type 1 Diabetes
Abstract
<html> <head> </head> <body> <span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none"><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px">Type 1 Diabetes (T1D) is a disease that affects ~1% of Canadians and is characterized by the death of insulin-producing beta cells within the pancreas. Insulin is an essential protein that triggers cells to absorb digested sugar (glucose) from the bloodstream for energy and storage. As the body&#8217;s only source of circulating insulin, beta cell death in T1D traps glucose in the blood and cells are starved of energy.</font></span><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px"><br align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">Genetic predispositions are known to contribute to T1D by causing the body&#8217;s immune system to attack and destroy beta cells (autoimmunity). However, recent research has shown that beta cell stress and subsequent dysfunction may also have a role in beta cell death. Insulin production is a complex process which can stress beta cells. This stress increases the likelihood of faulty insulin production, which can cause the cell to activate suicide pathways, and possibly trigger an autoimmune reaction against these dysfunctional beta cells.</span><br align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">We propose that decreasing insulin production will alleviate stress, thereby increasing beta cell survival and delaying diabetes onset. We plan to test this hypothesis by using mice predisposed to develop T1D and genetically reduce insulin production levels by injecting a beta cell-specific viral vector carrying an insulin-gene modifier. We will monitor diabetes incidence in the mice and measure biomarkers for beta cell stress and autoimmunity.</span><br align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">While no cure currently exists for T1D, enhanced screening technology enables earlier detection of pre-diabetic patients. Understanding why beta cells die is essential to the development of future therapeutics. Preventative medicine could prolong beta cell survival and help maintain natural insulin production, changing the outcome of T1D predisposition.</span></font> </body> </html>
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nahirney, Natalie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~